| Literature DB >> 31529490 |
M Bustamante1,2,3,4, C Hernandez-Ferrer1,3,4,5, A Tewari6, Y Sarria1,3,4, G I Harrison6, E Puigdecanet7, L Nonell7, W Kang8, M R Friedländer8, X Estivill2,3,4,9, J R González1,3,4, M Nieuwenhuijsen1,3,4, A R Young6.
Abstract
BACKGROUND: Terrestrial ultraviolet (UV) radiation causes erythema, oxidative stress, DNA mutations and skin cancer. Skin can adapt to these adverse effects by DNA repair, apoptosis, keratinization and tanning.Entities:
Mesh:
Year: 2019 PMID: 31529490 PMCID: PMC7318624 DOI: 10.1111/bjd.18527
Source DB: PubMed Journal: Br J Dermatol ISSN: 0007-0963 Impact factor: 9.302
Anthropometric and dermatological characteristics of the seven male participantsa
| Participant | Age, years | Anthropometrics | Dermatological/pigmentation parameters | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Height, m | Weight, kg | Hair colour | Eye colour | Complexion | Suntan | Sunburn | Freckles | ||
| ICE_003 | 31 | 1·83 | 74 | Brown | Brown | Pale | Light | Often | + |
| ICE_004 | 24 | 1·78 | 71 | Dark brown | Brown | Pale | Light | Often | + |
| ICE_005 | 25 | 1·73 | 63 | Blond | Blue | Pale | Light | Often | 0 |
| ICE_006 | 22 | 1·83 | 79 | Blond | Green | Pale | Light | Often | 0 |
| ICE_007 | 20 | 1·77 | 72 | Dark brown | Blue | Pale | Light | Often | + |
| ICE_008 | 20 | 1·77 | 67 | Brown | Brown | Pale | Faint | Often | 0 |
| ICE_009 | 35 | 1·88 | 120 | Brown | Blue | Pale | Faint | Always | + |
All participants were men with skin type II, according to Fitzpatrick scale.
Summary of the number of statistically significant genes at 5% false discovery rate (FDR) and their effect size after different fluorescent solar‐simulated radiation dose and time after exposure
| Time, dose (sample size | Genes at 5% FDR, | Mean Log2FC | Median Log2FC | Min Log2FC | Max Log2FC |
|---|---|---|---|---|---|
| 6 h | |||||
| 3 SED vs. 0 SED (7 vs. 5) | |||||
| All | 132 | 0·576 | 0·552 | 0·269 | 1·322 |
| Downregulated | 58 | –0·622 | –0·577 | –0·333 | –1·322 |
| Upregulated | 74 | 0·539 | 0·528 | 0·269 | 1·031 |
| 6 SED vs. 0 SED (6 vs. 5) | |||||
| All | 4071 | 0·651 | 0·606 | 0·199 | 2·002 |
| Downregulated | 1766 | –0·609 | –0·571 | –0·220 | –1·825 |
| Upregulated | 2305 | 0·684 | 0·640 | 0·199 | 2·002 |
| 24 h | |||||
| 3 SED vs. 0 SED (7 vs. 7) | |||||
| All | 16 | 0·892 | 0·816 | 0·582 | 1·592 |
| Downregulated | 10 | –0·949 | –0·822 | –0·662 | –1·592 |
| Upregulated | 6 | 0·798 | 0·765 | 0·582 | 0·982 |
| 6 SED vs. 0 SED (6 vs. 7) | |||||
| All | 1583 | 0·650 | 0·592 | 0·209 | 1·967 |
| Downregulated | 586 | –0·571 | –0·546 | –0·209 | –1·411 |
| Upregulated | 997 | 0·697 | 0·651 | 0·231 | 1·967 |
Log2FC: Log2 fold change; SED, standard erythemal doses. aSamples not included: ICE_003_A, ICE_004_A, ICE_004_E, ICE_004_F; bLog2FC for genes differently expressed at 5% FDR; cAbsolute |Log2FC|.
Figure 1Volcano plots of gene expression in skin after fluorescent solar‐simulated radiation exposure (different doses and time points). Plots show effect size log2 fold change (Log2FC) vs. –log10(P‐value). (a) and (b) show dose effects at time 6 h; and (c) and (d) dose effects at 24 h. Genes that reached 5% false discovery rate are in red. The number of differently expressed genes is higher at the higher dose [6 standard erythemal doses (SED)] and earlier time after exposure (6 h). The change in their expression levels is also more pronounced at the higher dose (6 SED) and earlier time (6 h). All plots show rather symmetric patterns. However, at 6 SED, the number of upregulated genes is slightly increased and their Log2FC slightly stronger.
Figure 2Venn diagram of genes detected at 5% false discovery rate in skin after fluorescent solar‐simulated radiation exposure (different doses and time points). Overlap of differently expressed genes under different models: different time (6 h and 24 h) and different dose [3 standard erythemal doses (SED) and 6 SED].
Figure 3Comparison of the effect size of candidate genes after exposure to fluorescent solar‐simulated radiation (FSSR), ultraviolet (UV)A1 and UVB. (a) Genes detected under all conditions of FSSR exposure: ,,,,,,,,. (b) DNA repair and apoptosis genes: . (c) Immunity and inflammation genes: ,,,,. (d) Pigmentation genes. (d1) Tyrosinase complex: ,,; (d2) tyrosinase complex regulation (reg.): ,;; (d3) melanin synthesis regulation: ,; (d4) melanosome transport (trans.): ; (d5) melanoblast (melanobl.) migration (migr.) and differentiation (diff.): ,,; (d6) transcription factor: ; (d7) other: . (e) vitamin D genes: . y‐axis represents log2 fold change (Log2FC), scale adapted to each gene; x‐axis represents different exposure conditions: different wavelength [FSSR, UVA1 (340–400 nm) or UVB (300 nm)], dose [3 standard erythemal doses (SED), 6 SED or 1 minimal erythemal dose (MED) (~2 SED, ranging from 1·6 to 2·6 SED)], time after exposure (6 h or 24 h). For FSSR, Log2FC (–∆∆Ct) obtained in the quantitative polymerase chain reaction experiment are shown. *P < 0·05 compared with unexposed samples (0 SED); **P < 2·8E‐04 compared with unexposed samples (0 SED).
Figure 4Volcano plots of microRNA (miRNA) expression in skin after fluorescent solar‐simulated radiation (FSSR) exposure (different doses and time points). Plots show effect size log2 fold change (Log2FC) vs. –log10(P‐value). (a) and (b) show dose effects at time 6 h; and (c) and (d) dose effects at 24 h. Only four miRNAs survived multiple testing correction (shown in red). All plots show symmetric patterns. The size of the effects of FSSR on miRNA expression was smaller than on gene expression.
Figure 5microRNA (miRNA) expression in skin after fluorescent solar‐simulated radiation (FSSR) exposure (different doses and time points). Normalized miRNA expression levels and mean standard error (y‐axis) by FSRR dose (x‐axis) and time (6 h in black and 24 h in red). (a) hsa‐miR‐223‐3p [6 h–0 standard erythemal doses (SED) vs. 6 h–6 SED: P = 1·17E‐06] and (b) hsa‐miR‐146b‐5p (6 h–0 SED vs. 6 h–6 SED: P = 1·71E‐05); (c) hsa‐miR‐142‐5p (24 h 0 SED vs. 24 h 3 SED: P = 1·08E‐04) and (d) hsa‐miR‐204‐5p (24 h 0 SED vs. 24 h 3 SED: P = 9·52E‐05).